AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
5.38
+0.02 (0.37%)
At close: Aug 7, 2025, 4:00 PM
3.460
-1.920 (-35.69%)
Pre-market: Aug 8, 2025, 7:39 AM EDT
MorphoSys AG Market Cap
AVITA Medical has a market cap or net worth of $142.91 million as of August 8, 2025. Its market cap has decreased by -44.51% in one year.
Market Cap
142.91M
Enterprise Value
171.81M
1-Year Change
-44.51%
Ranking
Category
Stock Price
$5.38
Market Cap Chart
Since March 29, 2012, AVITA Medical's market cap has increased from $59.55M to $142.91M, an increase of 140.01%. That is a compound annual growth rate of 6.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 142.38M | -57.90% |
| Dec 31, 2024 | 338.19M | -4.00% |
| Dec 29, 2023 | 352.28M | 111.74% |
| Dec 30, 2022 | 166.38M | -44.28% |
| Dec 31, 2021 | 298.61M | -25.68% |
| Dec 31, 2020 | 401.79M | -58.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.87B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.21B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| UnitedHealth Group | 221.91B |
| Novartis AG | 221.76B |
| Novo Nordisk | 213.92B |